Concepedia

Author

Albert Abad

Hospital Universitari Germans Trias i PujolORCID

Also Known As

A Abad, A. Abad, A. Silva Abad, Albert Abad, Alireza Azadi Hossein Abad, Arlene Abad, Eduardo Díaz-Rubio, Álvaro Muñoz Abad

114

Publications

5.5K

Citations

31

H-Index

59

Concepts

All Affiliations

Hospital Universitari Germans Trias i PujolInstitut Català d'OncologiaHospital Universitario Reina SofíaHospital Clínico San CarlosMarqués de Valdecilla University Hospital
AA

About

Albert Abad is an author at Hospital Universitari Germans Trias i Pujol specializing in oncology, medicine, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

31

1.8K

2

Health Sciences

8

8

320

3

Cell Biology

6

6

279

4

Emergency Medicine

2

2

239

5

Engineering

1

1

64

Albert Abad

×

46

Publications

4.9K

Citations

28

H-Index

YearCitations

A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer

R. Rosell, José Gómez‐Codina, Carlos Camps,

New England Journal of Medicine

1994

1.3K

A Novel Anti-Apoptosis Gene: Re-expression of Survivin Messenger RNA as a Prognosis Marker in Non–Small-Cell Lung Cancers

Mariano Monzó, Rafael Rosell, Enriqueta Felip,

Journal of Clinical Oncology

1999

496

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

D. Machover, Eduardo Díaz‐Rubio, Aimery de Gramont,

Annals of Oncology

1996

433

Upper Extremity Deep Venous Thrombosis in Cancer Patients with Venous Access Devices - Prophylaxis with a Low Molecular Weight Heparin (Fragmin)

Manuel Monréal, A Alastrué, Miquel Rull,

Thrombosis and Haemostasis

1996

369

First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

Eduardo Díaz‐Rubio, Auxiliadora Gómez‐España, Bartomeu Massutí,

The Oncologist

2012

212

Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer

Pascal Piedbois, Marc Buyse, G.H. Blijham,

Journal of Clinical Oncology

1994

191

Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway

Vicenç Ruiz de Porras, Sara Bystrup, Anna Martínez‐Cardús,

Scientific Reports

2016

131

Platelet count and survival in patients with colorectal cancer--a preliminary study.

M. Monreal, J Fernández-Llamazares, Marta Piñol,

PubMed

1998

123

Platelet Count and Survival in Patients with Colorectal Cancer – a Preliminary Study

Manuel Monréal, Jaume Fernández-Llamazares, Marta Piñol,

Thrombosis and Haemostasis

1998

116

Irinotecan in Combination With Fluorouracil in a 48-Hour Continuous Infusion As First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

Javier Sastre, Eugenio Marcuello, B. Masutti,

Journal of Clinical Oncology

2005

98

Page 1